Potential Use of Cyclodextrins as Drug Carriers and Active Pharmaceutical Ingredients

被引:51
|
作者
Arima, Hidetoshi [1 ,2 ]
Motoyama, Keiichi [1 ]
Higashi, Taishi [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan
[2] Kumamoto Univ, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Program Leading Grad Sch, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan
关键词
cyclodextrin (CyD); drug delivery system (DDS); active pharmaceutical ingredient; non-viral vector; supramolecule; METHYL-BETA-CYCLODEXTRIN; TERNARY INCLUSION COMPLEX; SUSTAINED-RELEASE SYSTEM; PICK-C-DISEASE; IN-VITRO; ALPHA-CYCLODEXTRIN; PEGYLATED INSULIN; BIOCLEAVABLE POLYROTAXANES; FULMINANT-HEPATITIS; GAMMA-CYCLODEXTRINS;
D O I
10.1248/cpb.c16-00779
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclodextrins (CyDs) are extensively used in various fields, and especially have been widely utilized as pharmaceutical excipients and drug carriers in the pharmaceutical field. Owing to the multi -functional and biocompatible characteristics, CyDs can improve the undesirable properties of drug molecules. This review outlines the current application of CyDs in pharmaceutical formulations, focusing on their use as CyD-based drug carriers for several kinds of drugs. Additionally, CyDs have great potential as active pharmaceutical ingredients against various diseases with few side effects.
引用
收藏
页码:341 / 348
页数:8
相关论文
共 50 条
  • [21] Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients
    Ajazuddin
    Alexander, Amit
    Qureshi, Azra
    Kumari, Leena
    Vaishnav, Pramudita
    Sharma, Mukesh
    Saraf, Swarnlata
    Saraf, Shailendra
    FITOTERAPIA, 2014, 97 : 1 - 14
  • [22] Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development
    Puhlmann, Neele
    Vidaurre, Rodrigo
    Kuemmerer, Klaus
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192
  • [23] In-silico identification of the skin sensitisation potential of active pharmaceutical ingredients
    Cronin, M.
    Bajot, F.
    Enoch, S.
    Sakutu, Y.
    Madden, J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 : A17 - A18
  • [24] Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA
    Arima, Hidetoshi
    Motoyama, Keiichi
    Higashi, Taishi
    PHARMACEUTICALS, 2012, 5 (01) : 61 - 78
  • [25] Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs
    Aitipamula, Srinivasulu
    Chow, Pui Shan
    Tan, Reginald B. H.
    CRYSTENGCOMM, 2009, 11 (09): : 1823 - 1827
  • [26] On Secondary Patenting of Organic Compounds Suitable for use as Active Pharmaceutical Ingredients
    Goizman, M. S.
    Shimanovskii, N. L.
    Zotova, O. A.
    Ryzhkov, I. O.
    Popova, A. O.
    Chernobrovkin, M. G.
    Korlyukov, A. A.
    Suponitskii, K. Yu.
    Sinel'nikov, A. V.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2019, 53 (09) : 876 - 882
  • [27] On Secondary Patenting of Organic Compounds Suitable for use as Active Pharmaceutical Ingredients
    M. S. Goizman
    N. L. Shimanovskii
    O. A. Zotova
    I. O. Ryzhkov
    A. O. Popova
    M. G. Chernobrovkin
    A. A. Korlyukov
    K. Yu. Suponitskii
    A. V. Sinel’nikov
    Pharmaceutical Chemistry Journal, 2019, 53 : 876 - 882
  • [28] Use of prediction methods to estimate true density of active pharmaceutical ingredients
    Cao, Xiaoping
    Leyva, Norma
    Anderson, Stephen R.
    Hancock, Bruno C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 355 (1-2) : 231 - 237
  • [29] Peptides as carriers of active ingredients: A review
    Nie, Congyi
    Zou, Yuxiao
    Liao, Sentai
    Gao, Qunyu
    Li, Qian
    CURRENT RESEARCH IN FOOD SCIENCE, 2023, 7
  • [30] Drug repurposing tactics in the USA: Known active pharmaceutical ingredients in new indications
    Dooley, Thomas P.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2025, 89